Active

Invigo Therapeutics

Switched

BE0789481317

Rechtspersoon Private limited company 1 establishment

Nonnenstraat 23, 2800 Mechelen Vervaardiging van overige farmaceutische producten

Active for

4 year, 1 month

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ -7,311

▼ 2537% vs 2024

Profit

Caution

€ -16,600

▼ 4559% vs 2024

Debts

High

€ 7,904

▼ 14% vs 2024

Invigo Therapeutics from Mechelen, company number BE0789481317, closed financial year 2025 with a result of € -16,600 after tax. For that financial year Invigo Therapeutics recorded a gross margin of € -7,311 and equity of € -6,956. Compared with financial year 2024, the result moved from € -356 to € -16,600. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 31, 2025.

What happened at Invigo Therapeutics?

What happened at Invigo Therapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 16,600. Source: NBB ↗
  • New establishment in Mechelen. KBO
  • Start of the company according to the CBE. KBO

In short

From € 356 loss in 2024 to € 16,600 loss in 2025.

A new publication or filing at Invigo Therapeutics? We notify you, reason included.

Follow Invigo Therapeutics

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Behind Invigo Therapeutics is LIFE of SCI BV. LIFE of SCI BV is also behind Temmune Therapeutics.

See the full network in the app

Directors

According to the 2025 annual accounts

LIFE of SCI BV

Director · represented by Joris De Maeyer

Also active at: Temmune Therapeutics

Establishments

Establishment units

Physical locations of this company

Registered office

Nonnenstraat 23

2800 Mechelen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0789.481.317
VAT number
BE 0789.481.317
Registered office
Nonnenstraat 23, 2800 Mechelen
Names & denominations
Invigo Therapeutics
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
8 August 2022
Peppol
Active · Active since 12 Dec 2025
Activities · NACE

Vervaardiging van overige farmaceutische producten

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Vervaardiging van geneesmiddelen

Overige gespecialiseerde wetenschappelijke en technische activiteiten

Frequently asked questions

What is the enterprise number of Invigo Therapeutics?
The enterprise number of Invigo Therapeutics is BE0789481317.
What is the address of Invigo Therapeutics?
The registered office of Invigo Therapeutics is located at Nonnenstraat 23, 2800 Mechelen.
When was Invigo Therapeutics founded?
Invigo Therapeutics was founded on 8 August 2022.
What is the main activity of Invigo Therapeutics?
The main activity of Invigo Therapeutics is "Vervaardiging van overige farmaceutische producten" (NACE code 21209).
Does Invigo Therapeutics have a website?
No website is currently known for Invigo Therapeutics.
How much profit did Invigo Therapeutics make in 2025?
Invigo Therapeutics recorded a loss after taxes of € 16,600 in financial year 2025.
What is the revenue of Invigo Therapeutics?
As a small company, Invigo Therapeutics is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -7,311.
Where can I find the annual accounts of Invigo Therapeutics?
Invigo Therapeutics files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Invigo Therapeutics?
According to the 2025 annual accounts, the directors of Invigo Therapeutics are: LIFE of SCI BV.
Who owns Invigo Therapeutics?
Behind Invigo Therapeutics is LIFE of SCI BV. LIFE of SCI BV is also behind Temmune Therapeutics.